Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis

Full text
Show less -
Gouvea, E. S. ; Ota, V. K. ; Noto, C. ; Santoro, M. L. ; Spindola, L. M. ; Moretti, P. N. ; Carvalho, C. M. ; Xavier, G. ; Rios, A. C. ; Sato, J. R. ; Hayashi, M. A. F. ; Brietzke, E. ; Gadelha, A. ; Bressan, R. A. ; Cordeiro, Q. ; Belangero, S. I.
Total Authors: 16
Document type: Journal article
Web of Science Citations: 9

Psychotic disorders affect similar to 3% of the general population and are among the most severe forms of mental diseases. In early stages of psychosis, clinical aspects may be difficult to distinguish from one another. Undifferentiated psychopathology at the first-episode of psychosis (FEP) highlights the need for biomarkers that can improve and refine differential diagnosis. We investigated gene expression differences between patients with FEP-schizophrenia spectrum (SCZ; N = 53) or FEP-Mania (BD; N = 16) and healthy controls (N = 73). We also verified whether gene expression was correlated to severity of psychotic, manic, depressive symptoms and/or functional impairment. All participants were antipsychotic-naive. After the psychiatric interview, blood samples were collected and the expression of 12 psychotic-disorder-related genes was evaluated by quantitative PCR. AKT1 and DICER1 expression levels were higher in BD patients compared with that in SCZ patients and healthy controls, suggesting that expression of these genes is associated more specifically to manic features. Furthermore, MBP and NDEL1 expression levels were higher in SCZ and BD patients than in healthy controls, indicating that these genes are psychosis related (independent of diagnosis). No correlation was found between gene expression and severity of symptoms or functional impairment. Our findings suggest that genes related to neurodevelopment are altered in psychotic disorders, and some might support the differential diagnosis between schizophrenia and bipolar disorder, with a potential impact on the treatment of these disorders. (AU)

FAPESP's process: 11/50740-5 - Prevention in schizophrenia and bipolar disorder from neuroscience to the community: a multiphase, multimodal and translational platform for research and intervention
Grantee:Rodrigo Affonseca Bressan
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 14/50830-2 - Biomarkers of treatment naive psychosis
Grantee:Rodrigo Affonseca Bressan
Support Opportunities: Regular Research Grants
FAPESP's process: 12/12686-1 - Potential genetic markers in early phases of schizophrenia
Grantee:Marcos Leite Santoro
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 13/10498-6 - Machine learning in neuroimaging: development of methods and clinical applications in psychiatric disorders
Grantee:João Ricardo Sato
Support Opportunities: Regular Research Grants
FAPESP's process: 10/08968-6 - Investigation of genetic and epigenetic markers: a translational approach for schizophrenia treatment
Grantee:Síntia Iole Nogueira Belangero
Support Opportunities: Regular Research Grants
FAPESP's process: 14/07280-1 - Search for genetic markers of risk, progression and response to treatment
Grantee:Síntia Iole Nogueira Belangero
Support Opportunities: Regular Research Grants